Biorithm
Company

Last deal

$3.5M

Amount

Series A

Stage

18.12.2023

Date

2

all rounds

$3.5M

Total amount

General

About Company
Biorithm develops affordable medical device technologies for patients' health and well-being.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company's co-founding team, with medical and engineering backgrounds, conducts medical studies at local hospitals to engineer solutions that address medical needs. Biorithm partners with higher learning institutions and industry to ensure engineering excellence. The company operates a remote monitoring platform that combines proprietary data analytics software and medical-grade wearables to monitor pregnancy vital data, including fetal heart rate, uterine contractions, and maternal heart rate. This provides clinicians with new insights into the health of the mother and baby, while offering expecting mothers better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications.
Contacts

location

Social url